IVD
Online Inquiry

Influenza A+B rapid test kit

Cat.No: IP-00186 Datasheet

Specification Quantities

25 T:
- +
Product Details Background Product Features Product Advantages Related Products
Product Name Influenza A+B rapid test kit
Catalog No. IP-00186
Description The influenza A+B rapid test kit is a diagnostic tool used to quickly detect the presence of influenza A+B in humans.
Sample Type Swab/nasal aspirate
Application This product can be used for rapid in vitro screening of influenza A+B.
Operating Temperature Store at 4-30°C.
Transportation Condition Transportation at room temperature.

Influenza A&B Rapid Test Kit, also known as the Flu A&B Rapid Diagnostic Test, is a crucial tool in the rapid detection of influenza viruses. Influenza, commonly referred to as the flu, is a highly contagious respiratory illness caused by influenza viruses. It affects millions of people worldwide each year, leading to significant morbidity and mortality.

The virus is categorized into three types: A, B, and C, with types A and B being the primary causes of seasonal flu epidemics. Influenza A viruses are further classified based on H (hemagglutinin) and N (neuraminidase) antigens, with strains like H1N1 and H3N2 being particularly notable. Early and accurate diagnosis of influenza is essential for effective treatment and containment of outbreaks.

Over the years, various diagnostic methods have been developed to detect influenza viruses. Traditional methods like viral culture and RT-PCR, while highly accurate, are time-consuming and require specialized laboratory settings. The advent of rapid influenza diagnostic tests (RIDTs) has revolutionized the field by offering quick results within 15 minutes, making them ideal for point-of-care use. The Influenza A&B Rapid Test Kit is designed to detect influenza A and B viral antigens in respiratory specimens, providing a qualitative result that aids in the rapid diagnosis and management of flu infections.

·Rapid Results: Delivers accurate results within 15 minutes, enabling quick clinical decision-making.
·User-Friendly: Simple three-step procedure makes it easy to use, even in non-laboratory settings.
·Comprehensive Detection: Simultaneously detects both influenza A and B viruses in a single test.
·High Sensitivity and Specificity: Demonstrates high clinical sensitivity and specificity, ensuring reliable results.
·Convenient Sampling: Allows for sample collection using either nasal or throat swabs, minimizing patient discomfort.
No Equipment Required: Can be performed without the need for specialized equipment, making it suitable for point-of-care use.

·Time-Efficient: Provides results in a clinically relevant timeframe, reducing the need for prolonged testing and enabling prompt treatment.
·Cost-Effective: Eliminates the need for expensive laboratory equipment and extensive training, making it accessible to a broader range of healthcare settings.
·Versatile Application: Suitable for use in various settings, including clinics, hospitals, and even at-home testing, enhancing its applicability.
·Reduced Antibiotic Use: By providing rapid and accurate diagnosis, it helps in reducing unnecessary antibiotic prescriptions, contributing to better patient outcomes.
·Supports Outbreak Management: Useful in identifying and managing outbreaks in settings like nursing homes, schools, and cruise ships.

For in vitro diagnostic use.

0
0

There is no product in your cart.